Assemblymember Natha Anderson introduced Assembly Bill 234 on the Ways and Means Committee floor, saying the bill "is to protect access to cancer screens for Nevada Medicaid beneficiaries and increase access to all evidence-based colorectal cancer screening options." The sponsor said the bill initially would have expanded colorectal cancer screening to include at-home DNA stool testing (Cologuard) in line with U.S. Preventive Services Task Force recommendations but that expansion produced a significant fiscal note.

Anderson told the committee that, because the fiscal impact would affect the general fund, the Nevada Cancer Coalition offered an amendment that removes the Medicaid expansion for at-home DNA stool testing and thereby removes the fiscal note. Stacy Weeks of Nevada Medicaid confirmed at the hearing that "there is no fiscal note with this amendment." Carrie Harrington, executive director of the Nevada Cancer Coalition, said the bill also aims to ensure parity between Medicaid and insured populations: "This bill protects all cancer screenings for Medicaid recipients ensuring parity with our insured population." Representatives of the Nevada Public Health Association and the Professional Firefighters in Nevada also voiced support.

The bill hearing closed with no callers on either side and with the sponsor offering no closing remarks. The proposal, as amended at the hearing, no longer includes the proposed Medicaid expansion for at-home DNA stool testing and therefore has no fiscal note per Nevada Medicaid testimony.

The committee did not take a formal vote during this hearing; the item was presented as a fiscal hearing and the sponsor introduced a budget amendment to remove the fiscal impact.